OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years
Hannah N. Corman, Case W. McNamara, Malina A. Bakowski
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2845-2845
Open Access | Times Cited: 7
Hannah N. Corman, Case W. McNamara, Malina A. Bakowski
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2845-2845
Open Access | Times Cited: 7
Showing 7 citing articles:
2-Aminothiophene Derivatives—New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
Rodrigo Santos Aquino de Araújo, Vitória Gaspar Bernardo, Robert da Silva Tibúrcio, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 125-125
Open Access
Rodrigo Santos Aquino de Araújo, Vitória Gaspar Bernardo, Robert da Silva Tibúrcio, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 125-125
Open Access
Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis
Camila M. Clemente, Javier Murillo, Ariel G. Garro, et al.
Parasitology Research (2024) Vol. 123, Iss. 4
Open Access | Times Cited: 4
Camila M. Clemente, Javier Murillo, Ariel G. Garro, et al.
Parasitology Research (2024) Vol. 123, Iss. 4
Open Access | Times Cited: 4
Anti-Leishmania major Properties of Nuphar lutea (Yellow Water Lily) Leaf Extracts and Purified 6,6′ Dihydroxythiobinupharidine (DTBN)
Orit Shmuel, Aviv Rasti, Melodie Zaknoun, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 384-384
Open Access
Orit Shmuel, Aviv Rasti, Melodie Zaknoun, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 384-384
Open Access
Serological Screening and Risk Factors Associated with Leishmania infantum Positivity in Newly Diagnosed HIV Patients in Greece
Chrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria Tsoumani, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1397-1397
Open Access
Chrysa Voyiatzaki, Apollon Dareios Zare Chormizi, Maria Tsoumani, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1397-1397
Open Access
Investigation new drugs for the treatment of leishmaniasis
Shyam Sundar, Vishal Singh, Neha Agrawal, et al.
Expert Opinion on Investigational Drugs (2024), pp. 1-18
Closed Access
Shyam Sundar, Vishal Singh, Neha Agrawal, et al.
Expert Opinion on Investigational Drugs (2024), pp. 1-18
Closed Access
Compared Antileishmanial Activity of Clomiphene and Tamoxifen
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2290-2290
Open Access
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2290-2290
Open Access
Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by Leishmania major
Parastoo Hassani Abharian, Seyedamirmehdi Hejazi Dehaghani, Zabihollah Shahmoradi, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
Parastoo Hassani Abharian, Seyedamirmehdi Hejazi Dehaghani, Zabihollah Shahmoradi, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
